Why small parcels are a big test for contract pharma

Published: 20-Aug-2025

As pharmaceutical logistics evolve, the growing importance of small parcel shipments is putting contract manufacturers to the test in new and unprecedented ways

You need to be a subscriber to read this article.
Click here to find out more.

In today’s pharmaceutical landscape, complexity is the new normal, reports Delphine Perridy, Chief Commercial Officer at Envirotainer.

With decentralised clinical trials, personalised medicines and direct-to-patient therapies on the rise, pharma supply chains must move faster, smarter and more precisely than ever before.

As these needs grow, so too does the role of small parcel shipments. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

You may also like